Sanofi
English

COPD: Prioritizing Lung Health in Aging

Published on: November 18, 2026

Share

A healthcare provider uses a stethoscope to listen to a patient’s chest.
Prioritizing lung health is important for healthy aging and mitigating serious chronic respiratory diseases like COPD.

In conversations about healthy aging, our lungs are often overlooked, with other body systems being prioritized.i This blind spot can pave the way for the development and worsening of debilitating respiratory diseases like chronic obstructive pulmonary disease (COPD). To plan for a healthy future, lungs must become part of the aging conversation.  

Declining Lung Health and the Burden of COPD  

For older adults, conversations around age-related illnesses are typically dominated by conditions affecting the heart and brain. Lung function is not often part of regular health assessments, despite clear links between the respiratory system and age-related conditions like elevated blood pressure and cognitive decline. One of the most obvious links to deteriorating lung health is respiratory illness, such as chronic obstructive pulmonary disease (COPD).  

Affecting nearly 2 million Canadians,ii including both non- and former smokers, COPD is a chronic lung disease that causes difficulty breathing.iii  Since healthy lungs are critical for numerous other bodily functions, it’s not surprising that people living with COPD have a significantly higher risk for other serious health problems, turning a respiratory issue into a complex, multi-faceted burden, highlighting the importance of early diagnosis and treatment. 

The impact of COPD is contrasted by the lack of knowledge and awareness of how much of a threat it is to respiratory health. 

COPD is the fifth leading cause of death in Canadavii, with hospitalizations ranging from an estimated $10,000-$15,000 per stay.viii With an estimated 1 in 4 Canadians expected to develop COPD in their lifetime,ix the burden is growing, especially as the risk of developing COPD increases with age. 

Despite this, COPD remains under-recognized and underprioritized, with the general public remaining unaware of the nature of the condition and its impact. In a recent global survey only about half of the population were able to correctly identify COPD as a lung condition.x1 Moreover, more than 1 million Canadians remain undiagnosed and untreated for COPD.xi

Elevating Lung Health to Redefine Healthy Aging  

To alleviate this rising issue, regular lung function testing needs to be integrated into routine health visits to become a core pillar of preventative care, especially for older adults. In people at risk of COPD, regular lung function testing to diagnose the condition can also help identify and track progress on individuals who are more vulnerable to worse outcomes.  

Discussing respiratory health as part of the conversation on aging is crucial. It’s a key step to addressing the growing impact of COPD on Canadians and in helping to lessen the burden. With recent advances in treatment, now is the time to ensure Canadians living with COPD have more solutions that meet their unique needs.
James Guy

James Guy

Country Lead, Canada and General Manager, Specialty Care at Sanofi

Dr. Wald sees firsthand the burden of COPD on Canadians. “As Canada’s population continues to grow, so does the urgency to protect those most vulnerable, says Dr. Wald. “Respiratory illnesses continue to pose serious risks for older adults, which is why prioritizing respiratory health has never been more important. Greater awareness, earlier detection, and evidence-based respiratory care are critical to helping patients maintain their independence and quality of life. 

With lung health gaining greater recognition as a global health priority, policy reforms are needed to ensure that people living with COPD benefit from earlier diagnosis, timely intervention and high-quality long-term care. The WHO's Integrated Lung Health Resolution marks an important milestone by calling on Member States to strengthen prevention, early diagnosis and integrated management of chronic respiratory diseases, including COPD, helping to elevate lung health as a public health and policy priority. 

Shaping a Healthier Future with Healthier Lungs  

Prioritizing lung health can help reduce the development of serious chronic respiratory diseases like COPD, as well as overall disease burden for older adults. COPD symptoms are often severe, ranging from persistent coughing and excessive mucus production to debilitating shortness of breath that can make everyday activities challenging.xii Placing respiratory function as a central part of the healthy aging conversation starts with clearing the air on the state of lung health today. Sanofi is committed to elevating the importance of lung health to ensure every person has the chance to age with resilience. Together let’s lessen the global burden of COPD and make lung function a key part of the healthy aging conversation. 

Explore More

COPD Around the World: The Impact on Patients and Caregivers

Rethinking the Science of COPD

Helping Patients Breathe Better: Addressing Unmet Needs in Respiratory Care

References

[1] National Institutes of Health. (2025). Funding for Various Research, Condition, and Disease Categories (RCDC). Accessed May 27, 2026.

[2] Lung Health Foundation. Chronic obstructive pulmonary disease. Available at: https://lunghealth.ca/lung-disease/copd/.  

[3] Lung Health Foundation. What is COPD? Available at: https://lunghealth.ca/copd/ 

[4] Mittmann N, et al. Respir Med 2008;102:413–21.

[5] Amegadziei JE, et al. CMAJ 2023;195(35):E1172–9.

[6] Yan C, et al. Pharmacoecon Open 2023;7(3):493–505.

[7] COPD: A $10 Billion Threat to Canada’s Healthcare System by 2030. Lung Health Foundation. Available at: https://lunghealth.ca/copd-a-10-billion-threat-to-canadas-healthcare-system-by-2030/

[8] Yan C., et al. Pharmacoecon Open. 2023;7(3):493-505. 

[9] COPD: A $10 Billion Threat to Canada’s Healthcare System by 2030. Lung Health Foundation. Available at: https://lunghealth.ca/copd-a-10-billion-threat-to-canadas-healthcare-system-by-2030/

[10] Copenhagen Institute for Future Studies (2024). COPD Index. Accessed May 27, 2026

[11] COPD: A $10 Billion Threat to Canada’s Healthcare System by 2030. Lung Health Foundation. Available at: https://lunghealth.ca/copd-a-10-billion-threat-to-canadas-healthcare-system-by-2030/

[12] Sanofi Canada Media Room. Dupixent® (dupilumab injection) approved in Canada for adults with inadequately controlled Chronic Obstructive Pulmonary Disease (COPD). Available at: https://sanoficanada.mediaroom.com/2025-10-22-Dupixent-R-dupilumab-injection-approved-in-Canada-for-adults-with-inadequately-controlled-Chronic-Obstructive-Pulmonary-Disease-COPD.

MAT-CA-2601592-v1.0–11/2026